The image shows the word “STOP” in large, bold, white capital letters centered on a dark blue background.
White, bold, all-caps text reads “THE ATTACK ON PATIENTS & CLINICS” on a solid dark blue background. The words “THE ATTACK” are much larger than the rest of the text, drawing strong attention.
White bold text on a red background says “NO ON PROP 44” with “NO” and “44” in large font, and “ON PROP” in smaller font between them. The design is simple and direct, focused on the message.

This November 3rd Vote No on Proposition 44. Learn More

760.466.0800
Espanol
English
Careers
Pay My Bill
MyChart
Search
Search
Request Refills
Become a patient
The image shows the word “STOP” in large, bold, white capital letters centered on a dark blue background.
White, bold, all-caps text reads “THE ATTACK ON PATIENTS & CLINICS” on a solid dark blue background. The words “THE ATTACK” are much larger than the rest of the text, drawing strong attention.
White bold text on a red background says “NO ON PROP 44” with “NO” and “44” in large font, and “ON PROP” in smaller font between them. The design is simple and direct, focused on the message.

This November 3rd Vote No on Proposition 44. Learn More

The image shows the DAP Health logo. It features the lowercase letters “dap” in bold, overlapping circles of blue, purple, and orange beside the black text “DAP Health” in a clean, modern font on a light gray background.
Back to Leadership
A large orange semicircle dominates the right half of the image, extending beyond the edges, on a light gray background. The left side shows only a portion of the semicircle, creating a bold and simple abstract composition.
A middle-aged man with short, light gray hair and a trimmed beard wears a tan corduroy jacket over a blue button-up shirt. He looks calmly at the camera against a plain, light gray background.

Tim Garnett

Board Member

Dr. Timothy J. Garnett, M.D., is a seasoned physician-executive with over 30 years of experience in drug development, regulatory affairs, and medical safety. He served as Chief Medical Officer and Senior Vice President at Eli Lilly and Company from 2008 to 2021, overseeing global clinical operations and guiding multiple therapies from research to approval.

Trained in obstetrics and gynecology, Dr. Garnett previously practiced in women’s health and held clinical research roles at Organon Laboratories. He earned his MBBS from St. George’s Hospital Medical School in London and is a Fellow of both the Royal College of Obstetricians and Gynaecologists (FRCOG) and the Faculty of Pharmaceutical Medicine (FFPM).

Since retiring from Lilly, Dr. Garnett has remained active in the biotech sector, serving as a board member and advisor to companies including MapLight Therapeutics, Ophirex, Carmot Therapeutics, Ukko, and Lindus Health.

Ask Me Anything About DAP Health

Get fast, informative answers

Become a patient

Fill out the form below and a member from our team will contact you to schedule an appointment.

Please subscribe to receive updates on the latest DAP Health news and events

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name
Opt-in